CD40 PREFERENTIALLY COSTIMULATES ACTIVATION OF CD4(+) T-LYMPHOCYTES

被引:0
|
作者
CAYABYAB, M [1 ]
PHILLIPS, JH [1 ]
LANIER, LL [1 ]
机构
[1] DNAX RES INST MOLEC & CELLULAR BIOL INC,DEPT IMMUNOL,PALO ALTO,CA 94304
来源
JOURNAL OF IMMUNOLOGY | 1994年 / 152卷 / 04期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD40 is a membrane differentiation antigen constitutively expressed on B cells that induces B cell growth and Ig synthesis after ligation with anti-CD40 mAb or with the recently identified CD40 ligand (CD40L). CD40L is rapidly induced on T cells after activation with anti-CD3 mAb or mitogens. While CD40-CD40L interactions are clearly beneficial to B cells, we speculated that a reciprocal costimulation of T cells might also occur. We have used genetic transfection to demonstrate that interactions between human small, resting T cells and CD40(+) murine transfectants substantially augmented anti-CD3 induced T cell proliferation and resulted in the generation of CTL. T cell proliferation costimulated by CD40 was IL-2 dependent. The ability of CD40(+) transfectants to costimulate T cell proliferation was specific in that VCAM-1(+), CD54(+), CD72(+), CD56(+), CD31(+), and fas(+) transfectants in the same host cells were inactive. CD4(+) T cells preferentially responded to CD40 costimulation, whereas CD8(+) T cells were substantially less reactive. By contrast, costimulation with B7 transfectants induced equivalent proliferation in the CD4(+) and CD8(+) T cell subsets. in addition, adult naive and memory T cells, as well as cord blood T cells, were responsive to CD40. These findings suggest that the CD40-CD40L costimulation pathway may allow for selective expansion of CD4(+) T cells after interaction with CD40-bearing APC. The relatively restricted expression of CD40 on APC, as well as on medullary and cortical thymic epithelium, indicates a possible role for this interaction in T cell differentiation and activation.
引用
收藏
页码:1523 / 1531
页数:9
相关论文
共 50 条
  • [1] OLIGOCLONAL ACTIVATION OF CD4(+) T-LYMPHOCYTES IN POSTERIOR UVEITIS
    FERON, EJ
    CALDER, VL
    LIGHTMAN, SL
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 99 (03): : 412 - 418
  • [2] CD40 on NOD CD4 T cells contributes to their activation and pathogenicity
    Baker, Rocky L.
    Wagner, David H., Jr.
    Haskins, Kathryn
    JOURNAL OF AUTOIMMUNITY, 2008, 31 (04) : 385 - 392
  • [3] FUNCTION OF CD40 EXPRESSED ON HUMAN T-LYMPHOCYTES
    ATTREP, J
    BREZINSCHEK, HP
    BREZINSCHEK, RI
    LIPSKY, PE
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 232 - 232
  • [4] ALTERED CD40 LIGAND INDUCTION IN TOLERANT T-LYMPHOCYTES
    BOWEN, F
    HALUSKEY, J
    QUILL, H
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (10) : 2830 - 2834
  • [5] CYCLOSPORINE-A INHIBITS CD40 LIGAND EXPRESSION IN T-LYMPHOCYTES
    FULEIHAN, R
    RAMESH, N
    HORNER, A
    AHERN, D
    BELSHAW, PJ
    ALBERG, DG
    STAMENKOVIC, I
    HARMON, W
    GEHA, RS
    JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03): : 1315 - 1320
  • [6] IS PSORIASIS PRIMARILY A DISORDER OF EPIDERMAL CD4/CD8 T-LYMPHOCYTES AND EPIDERMAL REGENERATIVE ACTIVATION
    WOLFE, J
    NABEVA, R
    VALLAT, VP
    GILLEAUDEAU, P
    HEFTLER, NS
    KRUEGER, JG
    GOTTLIEB, AB
    CLINICAL RESEARCH, 1993, 41 (02): : A506 - A506
  • [7] Regulation of pathogenicity through CD40 expressed on CD4 T cells
    Baker, Rocky
    Wagner, David
    Haskins, Kathryn
    CLINICAL IMMUNOLOGY, 2007, 123 : S25 - S25
  • [8] IS PSORIASIS PRIMARILY A DISORDER OF EPIDERMAL CD4/CD8 T-LYMPHOCYTES AND EPIDERMAL REGENERATIVE ACTIVATION
    WOLFE, J
    NABEYA, R
    VALLAT, VP
    GILLEAUDEAU, P
    HEFTLER, NS
    KRUEGER, JG
    GOTTLIEB, AB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 598 - 598
  • [9] CD40 is a regulatory molecule on diabetogenic CD4 T-cells
    Baker, Rocky L.
    Wagner, David
    Haskins, Kathryn
    DIABETES, 2008, 57 : A352 - A352
  • [10] The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activation
    Brenner, B
    Koppenhoefer, U
    LeppleWienhues, A
    Grassme, H
    Muller, C
    Speer, CP
    Lang, F
    Gulbins, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 239 (01) : 11 - 17